In this two-part series, host Stuart Lowe examines two factors testing the resilience of the biopharma industry. As society simultaneously navigates a green transition alongside an AI revolution, so the biopharma industry faces mounting pressure to address its carbon emissions, deploy cutting-edge digital technology, while streamlining operations. Along with his guests, discover the innovative approaches that are being taken to transform drug development and manufacturing.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör TTP plc. Innehållet i podden är skapat av TTP plc och inte av, eller tillsammans med, Poddtoppen.